{"id":225744,"date":"2026-09-27T16:31:19","date_gmt":"2026-09-27T16:31:19","guid":{"rendered":"https:\/\/quixnet.net\/wpinstance\/current-breaking-news-national-world-updates-time-com\/"},"modified":"2026-09-27T16:31:19","modified_gmt":"2026-09-27T16:31:19","slug":"current-breaking-news-national-world-updates-time-com","status":"publish","type":"post","link":"https:\/\/quixnet.net\/wpinstance\/current-breaking-news-national-world-updates-time-com\/","title":{"rendered":"Current & Breaking News | National & World Updates – time.com"},"content":{"rendered":"

Personalized Content
Follow this author to personalize your feed and get instant alerts.
WHY FOLLOW?
Update your preferences in Account Settings<\/a>
Reporter
David Sinclair, a professor at Harvard Medical School, has said<\/a> that he thinks the first person who will live to the age of 150 is already alive today. During a panel discussion about longevity at the TIME100 Health Leadership Forum in New York City on Sept. 10, TIME executive editor Nikhil Kumar asked Sinclair what motivated him to say that.
\u201cChildren born today will live into the 22nd century, and just think about in the last five years what\u2019s happened to our world; it\u2019s barely recognizable when it comes to AI and even the healthcare world,\u201d Sinclair replied. \u201cSo, in the 22nd century, children born today are going to have access to technologies that we literally cannot even imagine now.\u201d
Advertisement
Sinclair was joined on stage by Jennifer Garrison, a neuroscientist with expertise in the women\u2019s health biotech field, and Jack Jia, the founder and CEO of Musely, a telehealth platform aimed at expanding access to personalized prescription care that sponsored the event on Sept. 10.
Garrison\u2019s longevity work focuses largely on women\u2019s health, in particular on ovaries<\/a>\u2014something she said affects not just women, but everyone, because \u201cunderstanding the differences between male bodies and female bodies gives us levers with which to develop medicines.\u201d
\u201cWhen we miss female physiology, we\u2019ve essentially left out half of the picture,\u201d she said.
For example, she said, female bodies tend to be better at fighting viruses than male bodies. Researchers don\u2019t fully understand why, but if they were able to understand those differences, it could help better equip the medical community to treat everyone depending on their needs, Garrison argued.
When Kumar asked her how far along the medical field is in understanding these differences, Garrison replied, \u201cWe\u2019re pretty far behind, as it turns out.\u201d But, she continued, \u201cEveryone understands that there\u2019s a challenge here that we\u2019ve got a data gap, that we\u2019ve got this systemic bias about our research, that we\u2019re essentially, I think, generations behind.\u201d
\u201cIt\u2019s not years. It\u2019s not decades. It\u2019s generations behind in terms of the data,\u201d she said. \u201cSo we\u2019re catching up, but it\u2019s going to take a while.\u201d
During the conversation, Jia shared that he was inspired to expand Musely beyond being a skincare tip platform after his wife\u2019s struggle to find effective treatments for her melasma<\/a>.
\u201cThis kind of wellness or cosmetics conditions are everyone\u2019s problem,\u201d Jia said. But \u201cthe entire healthcare system is not designed to solve that problem; it\u2019s designed to solve that real sick person who is dying.\u201d
Since then, Jia has broadened Musely\u2019s scope to include resources and treatments for proactive health and longevity.
Kumar went on to ask the panelists what they think about the recent \u201cexplosion in testing\u201d in the longevity space\u2014how people are getting all kinds of tests and scans to, they claim, optimize living longer and better. Garrison said that, where there is evidence for the test, it\u2019s a great option. But that is not always the case.
\u201cI think we can all acknowledge that there\u2019s a little bit of a credibility issue in the longevity space, and a lot of the products that are marketed are either poorly supported by evidence or outright pseudoscience,\u201d Garrison said. \u201cFor women, the amount of information and marketing that comes at us these days is crazy. And part of the problem is that it\u2019s very hard as a consumer, as someone who\u2019s not a scientist or a doctor, to really make the call between, \u2018Is this real or not?\u2019\u201d
Sinclair expressed concerns that what people used to consider to be \u201cfringe\u201d behaviors, such as injecting oneself with peptides or taking drugs that have not yet been proven to be effective in humans, is becoming more common.
\u201cI wonder where we\u2019re going to go,\u201d he said. \u201cBut I do applaud the fact that people do have the right, with their doctors \u2026 to try something if there\u2019s nothing else that works, and there\u2019s no seemingly bad downside.\u201d
\u201cI thought that five years ago, in my opinion, the regulations were so strict that even people who were suffering or dying couldn\u2019t get medicines,\u201d he continued. \u201cThat was too extreme in my view, but we\u2019ve gone with the other extreme.\u201d
The TIME100 Health Leadership Forum was presented by the American Cancer Society, Kite\u2014a Gilead Sciences company, Insulet, Musely, and NMDP.<\/em>
Advertisement
\u00a9 2026 TIME USA, LLC. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Service<\/a>, Privacy Policy<\/a> and